Literature DB >> 15717947

Intensity-modulated radiotherapy: is xerostomia still prevalent?

Mark S Chambers1, Adam S Garden, David Rosenthal, Anesa Ahamad, David L Schwartz, Angel I Blanco, K S Clifford Chao, William H Morrison, K Kian Ang, Randal S Weber.   

Abstract

Conformal radiation with intensity-modulated radiotherapy (IMRT) is a technique that potentially can minimize the dose to salivary glands and thereby decrease the incidence of xerostomia. Precise target determination and delineation is most important when using salivary gland-sparing techniques of IMRT. Reduction of xerostomia can be achieved by sparing the salivary glands on the uninvolved oral cavity and keeping the mean parotid gland dose of less than 26 to 30 Gy as a planning criterion if the treatment of disease is not compromised and parotid function preservation is desired.

Entities:  

Mesh:

Year:  2005        PMID: 15717947     DOI: 10.1007/s11912-005-0039-4

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  29 in total

Review 1.  Partial irradiation of the parotid gland.

Authors:  A Eisbruch; J A Ship; H M Kim; R K Ten Haken
Journal:  Semin Radiat Oncol       Date:  2001-07       Impact factor: 5.934

2.  Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

Authors:  K Sultanem; H K Shu; P Xia; C Akazawa; J M Quivey; L J Verhey; K K Fu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-10-01       Impact factor: 7.038

3.  Prevention of xerostomia-related dental caries in irradiated cancer patients.

Authors:  S Dreizen; L R Brown; T E Daly; J B Drane
Journal:  J Dent Res       Date:  1977-02       Impact factor: 6.116

4.  Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques.

Authors:  K S Chao; N Majhail; C J Huang; J R Simpson; C A Perez; B Haughey; G Spector
Journal:  Radiother Oncol       Date:  2001-12       Impact factor: 6.280

5.  Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.

Authors:  A Eisbruch; H M Kim; J E Terrell; L H Marsh; L A Dawson; J A Ship
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-07-01       Impact factor: 7.038

6.  The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region.

Authors:  B O'Sullivan; P Warde; B Grice; C Goh; D Payne; F F Liu; J Waldron; A Bayley; J Irish; P Gullane; B Cummings
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

7.  Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience.

Authors:  K S Chao; D A Low; C A Perez; J A Purdy
Journal:  Int J Cancer       Date:  2000-04-20       Impact factor: 7.396

8.  Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy.

Authors:  B S Henson; M R Inglehart; A Eisbruch; J A Ship
Journal:  Oral Oncol       Date:  2001-01       Impact factor: 5.337

Review 9.  Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets.

Authors:  Avraham Eisbruch; Robert L Foote; Brian O'Sullivan; Jonathan J Beitler; Bhadrasain Vikram
Journal:  Semin Radiat Oncol       Date:  2002-07       Impact factor: 5.934

10.  Level II lymph nodes and radiation-induced xerostomia.

Authors:  Eleftheria Astreinidou; Homan Dehnad; Chris H J Terhaard; Cornelis P J Raaijmakers
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-01-01       Impact factor: 7.038

View more
  8 in total

1.  Superficial parotid lobe-sparing delineation approach: a better method of dose optimization to protect the parotid gland in intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  H B Zhang; X Lu; S M Huang; L Wang; C Zhao; W X Xia; S W Li; F L Wang; Y L Zhu; X Guo; Y Q Xiang
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

Review 2.  Organ-sparing radiation therapy for head and neck cancer.

Authors:  XiaoShen Wang; ChaoSu Hu; Avraham Eisbruch
Journal:  Nat Rev Clin Oncol       Date:  2011-07-26       Impact factor: 66.675

3.  Can sparing of the superficial contralateral parotid lobe reduce xerostomia following radiotherapy for head and neck cancer?

Authors:  Daan Nevens; Sandra Nuyts
Journal:  Br J Radiol       Date:  2017-10-03       Impact factor: 3.039

4.  Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study.

Authors:  Eva Onjukka; Claes Mercke; Einar Björgvinsson; Anna Embring; Anders Berglund; Gabriella Alexandersson von Döbeln; Signe Friesland; Giovanna Gagliardi; Clara Lenneby Helleday; Helena Sjödin; Ingmar Lax
Journal:  Front Oncol       Date:  2020-08-14       Impact factor: 6.244

Review 5.  IMRT for head and neck cancer: reducing xerostomia and dysphagia.

Authors:  XiaoShen Wang; Avraham Eisbruch
Journal:  J Radiat Res       Date:  2016-08       Impact factor: 2.724

6.  Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.

Authors:  Xin-Bin Pan; Yang Liu; Ling Li; Song Qu; Long Chen; Shi-Xiong Liang; Kai-Hua Chen; Zhong-Guo Liang; Xiao-Dong Zhu
Journal:  Aging (Albany NY)       Date:  2020-01-31       Impact factor: 5.682

7.  Evaluation of Salivary Gland Function Using Diffusion-Weighted Magnetic Resonance Imaging for Follow-Up of Radiation-Induced Xerostomia.

Authors:  Yunyan Zhang; Dan Ou; Yajia Gu; Xiayun He; Weijun Peng
Journal:  Korean J Radiol       Date:  2018-06-14       Impact factor: 3.500

8.  Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.

Authors:  Xin-Bin Pan; Yang Liu; Shi-Ting Huang; Kai-Hua Chen; Yan-Ming Jiang; Xiao-Dong Zhu
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.